Pfizer Inc PFE

Buzz on the Bullboards: Bombardier, world woes, a smart fridge, and top shelf weed

[Jonathon Brown]

A highlight of the week was Bombardier (TSX:BBD), which reported impressive growth in its Q3 2024 results. read article.

[PressRelease]

Chris Boshoff to lead all Research and Development functions including OncologyOncology Unit end-to-end structure to remain intact, reporting to BoshoffRoger Dansey to become Interim Chief Oncology Officer and Johanna Bendell to join Pfizer as Oncology Chief Development Officer Pfizer Inc...read article.

[PressRelease]

In the EU, HYMPAVZI is the first once-weekly subcutaneous treatment approved for eligible people living with severe hemophilia B and the first to be administered via a pre-filled pen or syringe for people living with severe hemophilia A or BHYMPAVZI’s approval is based on Phase 3 study results...read article.

[ecolo101]

Just over reaction at the moment. It generates money and there is too many projects on the table. glta dyodd

[ozkan123]

Just a question,  If you buy PFE on the Canadian NEO exchange, are you still eligible to receive dividends? and in US $$.  If so, then I'll assume that as long as it's in a RRSP then

[ecolo101]

Kennedy Junior got the head of the health department....ouch Just Watch him over the next year, hopefully somebody can find a best approach to discuss worm brain Disease ha ha ha. For those who heard

[ecolo101]

Tomorrow, so today was the day to get in. Dividend 6.12% annually so $1.68 or $0.42 per quarter. big pharma seems to be waiting to see if Kennedy will come on top nominated by Trump...this could be

[ecolo101]

Wait wait wait forget the dividend if it goes to a lower entrance point. dyodd

[ecolo101]

November 8th and if you are registered you will be eligible to $0.42 , not bad at all in a declining interest rate environment... glta dyodd

[whytestocks]

Just In: $PFE 3 Ultra-High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade2024-09-26 04:07:00 ET It will be over a decade before I start relying on dividend income from my stock portfolio.

[PressRelease]

First assessment from an RSV vaccine study in immunocompromised adults show ABRYSVO was well-tolerated and generated strong neutralizing responses after a single dose in adults ≥ 18 years of ageThese results add to the growing body of evidence indicating a single dose of ABRYSVO provides strong...read article.

[PressRelease]

Largest head-to-head randomized clinical trial between DTG/3TC and BIC/FTC/TAF, conducted by SEIMC-GeSIDA Foundation (FSG) showed DTG/3TC demonstrated non-inferior efficacy compared to BIC/FTC/TAF as a switch regimen for virologically-suppressed adults living with HIV over 48 weeks of therapy.DTG...read article.

[PressRelease]

Second-Quarter Performance Driven by Focused Commercial Execution Raises Full-Year 2024 Revenue Guidance(1) to a Range of $59.5 to $62.5 Billion and Raises Adjusted(2) Diluted EPS Guidance to a Range of $2.45 to $2.65 Launched Manufacturing Optimization Program with Anticipated Cost Savings of...read article.

[PressRelease]

A one-time dose of DURVEQTIX has reduced bleeds post-treatment compared to standard of care with a median annualized bleed rate (ABR) of zero bleeds (range 0 to 9.9) after up to four years of follow-up, providing sustained bleed protection and potentially avoiding years of treatment burden with...read article.

[ecolo101]

Some positive leg up , this is a good push when tech is going down, hopefully some $$$ just transfer for the right reason. Mid to long term investing in one of the largest pharmaceutical  ex date

[PressRelease]

Giroctocogene fitelparvovec study meets primary and key secondary objectives of superiority compared to prophylaxis Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 AFFINE study (NCT04370054) evaluating giroctocogene fitelparvovec, an investigational gene...read article.